학술논문

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Document Type
Article
Author
Brown, D.M.Wykoff, C.C.Boyer, D.S.Do, D.V.Sakamoto, T.Win, P.Joshi, S.Salehi-Had, H.Seres, A.Berliner, A.J.Vitti, R.Chu, K.W.Reed, K.Rao, R.Cheng, Y.Sun, W.Voronca, D.Bhore, R.Hirshberg, B.Yancopoulos, G.D.Leal, S.Zhang, X.Schmidt-Ott, U.Schmelter, T.Schulze, A.Sivaprasad, S.Abraham, P.Aderman, C.Akiyama, K.Alfaro, D.V.Ali, F.A.Amini, P.Anzalotta, A.E.Bátor, G.Batlle, I.Berger, A.Bhandari, R.Bridges, W.Brinkmann, C.Brown, J.Burgess, S.Calzada, J.Capone Jr., A.Cervena, D.Charles, S.Chaudhry, N.Chow, D.Clark, W.L.Conrad III, P.Cunningham, M.Dadgostar, H.Dessouki, A.Deupree, D.Devine, C.Eichenbaum, D.Ernest, J.Feltgen, N.Fenberg, M.Ferrone, P.Frenkel, R.Friedman, S.Gasperini, J.Gerstenblith, A.Ghorayeb, G.Giunta, M.Goff, M.Golas, L.Googe Jr., J.M.Goren Fein, J.Hagedorn, C.Hagiwara, A.Hahn, P.Hairston, R.Handza, J.Hau, V.Hayashi, K.Heier, J.Hershberger, V.Higgins, P.Hirano, Y.Honda, S.Ikegami, Y.Ishida, Y.Ishikawa, I.Ishii, K.Jablon, E.P.Jain, A.Kaji, Y.Kapoor, K.Kerényi, Á.Kimura, K.Kishino, G.Kiss, K.Kitaoka, T.Klancnik, J.M.Kobayashi, N.Kogo, J.Korda, V.Kruger, E.Kusuhara, S.Lara, W.Laud, K.Lee, S.Luu, J.Marcus, D.Mein, C.Meleth, A.Milibák, T.Mitamura, Y.Murata, T.Noge, S.Onoe, H.Osher, J.Papp, A.Parschauer, J.Patel, S.Patel, S.Pezda, M.Pirouz, A.Prasad, P.Punjabi, O.Rao, L.Roe, R.Schadlu, R.Schneider, E.Shah, A.Shah, M.Shah, S.Shah, S.Sharma, A.Sheth, V.Shimura, M.Singerman, L.Spital, G.Stoltz, R.Suan, E.Suzuma, K.Takahashi, H.Takamura, Y.Takeuchi, M.Tan, J.Thomas, B.Tóth,-Molnár, E.Ueda, T.Ushida, H.Vajas, A.Varma, D.Varsányi, B.Veith, M.Weber, P.Wee, R.Williams, G.Yamada, H.Yonekawa, Y.Yoshida, S.
Source
In: The Lancet. (The Lancet, 23 March 2024, 403(10432):1153-1163)
Subject
Language
English
ISSN
1474547X
01406736